1. Why New Treatments for Hyperhidrosis Should Be on Your Radar

3. This program will include a discussion of off-label treatment and devices and investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

4. Hyperhidrosis by the Numbers

5. Case 1 Sebastian

6. What Do Pediatricians Need to Know About HH?

7. QoL Is the Severity Scale

8. Treatment Options for Pediatric HH

9. Antiperspirants

10. How Antiperspirants Work

11. Iontophoresis

12. Case 2 Cassie

13. Evaluating the Adult Patient With HH

14. IHHS Treatment Algorithm

15. Oral Medications

16. Pathophysiology of HH

17. Considerations in Treatment Selection for Pediatric HH

18. Case 3 Patrick

19. Treatment Options for Patrick

20. OnobotulinumtoxinA

21. OnabotulinumtoxinA in Adolescent Patients

22. OnabotulinumtoxinA in Adult Patients

23. Managing Side Effects

24. Other Treatments

25. Topical Anticholinergic Glycopyrronium Tosylate in Adult and Adolescent Patients

26. Topical Anticholinergic Sofpironium Bromide in Adult Patients

27. Conclusion and Key Takeaways

28. Abbreviations